Lv43
446 积分 2024-05-27 加入
Anti-cancer drug combinations approved by US FDA from 2011 to 2021: main design features of clinical trials and role of pharmacokinetics
1天前
已完结
Zorevunersen in Children and Adolescents with Dravet Syndrome
1个月前
已完结
Zorevunersen in Children and Adolescents with Dravet Syndrome
1个月前
已完结
Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Phase CAR T Therapy Studies
4个月前
已完结
Backfilling Patients in Phase I Dose-Escalation Trials Using Bayesian Optimal Interval Design (BOIN)
4个月前
已完结
Survodutide Once Weekly for the Treatment of Adults with Obesity
4个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
4个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
4个月前
已关闭
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
4个月前
已完结
Cardiac safety of chronic inhibition of the myostatin–activin pathway with bimagrumab in healthy older adults
5个月前
已关闭
皖公网安备34019202002308
